Warning letter
Vesta Pharmaceuticals, Inc.: warning letter of Oct 5, 2001
FDA warning letter UCM178454 · Detroit District Office
Key facts
| Reference number | UCM178454 |
|---|---|
| Company | Vesta Pharmaceuticals, Inc. |
| Subject | Food Labeling/Lacks New Drug Application/Misbranded |
| Issue date | Oct 5, 2001 |
| Posted date | Oct 5, 2001 |
| Issuing office | Detroit District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.54, 101.36(e)(10), 101.9, 101.9(c)(9), 101.36, 101.36(b), 101.36(e), 101.54(f), 101.13(j) |
| Country | 3 |
| Inspection city | Indianapolis |
| Inspection ZIP | 46236-2866 |
| Inspection start date | Mar 10, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: